Litcius/Paper detail

Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial

Tamara S. Hannon, Lily C. Chao, Margarita Barrientos‐Pérez, Karthik Chandrasekhar Pamidipati, Laura Fernández Landó, Clare J. Lee, Hiren Patel, Brandon K. Bergman

2025The Lancet21 citationsDOI

Topics & Concepts

MedicineType 2 diabetesInternal medicinePhase (matter)PediatricsDiabetes mellitusClinical trialMEDLINEPhysical therapyPhases of clinical researchDiabetes Treatment and ManagementGastrointestinal motility and disordersDiabetes Management and Research
Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial | Litcius